Referencias

  1. Aliprandi P, Cima L, Carrara M. Therapeutic Use of Levocloperastine as an Antitussive Agent. Clinical Drug Investigation. 1 de abril de 2002;22(4):209-20.
  2. Satish K, Sholapuri D, Niranjane V, Garg S. Efficacy and Safety of Levocloperastine in the Treatment of Dry Cough: A Prospective Observational Study. J Assoc Physicians India. mayo de 2018;66(5):71-5.
  3. Aliprandi P, Castelli C, Bernorio S, Dell’Abate E, Carrara M. Levocloperastine in the treatment of chronic nonproductive cough: comparative efficacy versus standard antitussive agents. Drugs Exp Clin Res. 2004;30(4):133-41.
  4. French CL, Irwin RS, Curley FJ, Krikorian CJ. Impact of chronic cough on quality of life. Arch Intern Med. 10 de agosto de 1998;158(15):1657-61.
  5. P A, Cima L, M C. Therapeutic Use of Levocloperastine as an Antitussive Agent: An Overview of Preclinical Data and Clinical Trials in Adults and Children. Vol. 22. 2002. 209 p.